Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aviral Singh

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Nuclear Medicine Communications|May 20, 2006
Current practice in pancreatic imaging: the role of nuclear medicineAviral Singh, Adil Al-Nahhas, Zarni Win
PET Clinics|March 8, 2017
Imaging of Prostate Cancer Using <sup>64</sup>Cu-Labeled Prostate-Specific Membrane Antigen LigandAviral Singh, Harshad R Kulkarni, Richard P Baum
Seminars in Nuclear Medicine|August 25, 2016
Advances in the Diagnosis of Neuroendocrine NeoplasmsHarshad R Kulkarni, Aviral Singh, Richard P Baum
Analytical Chemistry|June 6, 2025
DuReS: An R Package for Denoising Experimental Tandem Mass Spectra and Metabolite AnnotationShayantan Banerjee, Prajval Nakrani, Aviral Singh, et al.
Frontiers in Endocrinology|August 11, 2025
Editorial: Functional neuroendocrine tumorsBojana Popovic, Francesca Spada, Aviral Singh, et al.
Clinical Nuclear Medicine|December 27, 2019
Twelve-Year Survival of a Patient With Lymph Node, Pulmonary, Bone, Cardiac and Intraspinal Metastases of a Rectal Neuroendocrine Neoplasm Treated With Peptide Receptor Radionuclide Therapy-The Value of Salvage Peptide Receptor Radionuclide TherapyJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Clinical Nuclear Medicine|August 7, 2018
Ten-Year Survival After Peptide Receptor Radionuclide Therapy of a Metastatic Well-differentiated G3 Pancreatic Neuroendocrine NeoplasmJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Clinical Nuclear Medicine|January 24, 2019
Delayed Response (Partial Remission) 3 Years After Peptide Receptor Radionuclide Therapy in a Patient Participating in the NETTER-1 TrialJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Clinical Nuclear Medicine|January 25, 2020
Successful Intra-arterial Peptide Receptor Radionuclide Therapy of DOTATOC-Negative High-Grade Liver Metastases of a Pancreatic Neuroendocrine Neoplasm Using 177Lu-DOTA-LM3: A Somatostatin Receptor AntagonistJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Clinical Nuclear Medicine|April 2, 2019
Prostate-Specific Membrane Antigen Accumulation in Lower Extremity LymphedemaJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Nuclear Medicine Communications|May 20, 2006
Current practice in pancreatic imaging: the role of nuclear medicineAviral Singh, Adil Al-Nahhas, Zarni Win
PET Clinics|March 8, 2017
Imaging of Prostate Cancer Using <sup>64</sup>Cu-Labeled Prostate-Specific Membrane Antigen LigandAviral Singh, Harshad R Kulkarni, Richard P Baum
Seminars in Nuclear Medicine|August 25, 2016
Advances in the Diagnosis of Neuroendocrine NeoplasmsHarshad R Kulkarni, Aviral Singh, Richard P Baum
Analytical Chemistry|June 6, 2025
DuReS: An R Package for Denoising Experimental Tandem Mass Spectra and Metabolite AnnotationShayantan Banerjee, Prajval Nakrani, Aviral Singh, et al.
Frontiers in Endocrinology|August 11, 2025
Editorial: Functional neuroendocrine tumorsBojana Popovic, Francesca Spada, Aviral Singh, et al.
Clinical Nuclear Medicine|December 27, 2019
Twelve-Year Survival of a Patient With Lymph Node, Pulmonary, Bone, Cardiac and Intraspinal Metastases of a Rectal Neuroendocrine Neoplasm Treated With Peptide Receptor Radionuclide Therapy-The Value of Salvage Peptide Receptor Radionuclide TherapyJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Clinical Nuclear Medicine|August 7, 2018
Ten-Year Survival After Peptide Receptor Radionuclide Therapy of a Metastatic Well-differentiated G3 Pancreatic Neuroendocrine NeoplasmJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Clinical Nuclear Medicine|January 24, 2019
Delayed Response (Partial Remission) 3 Years After Peptide Receptor Radionuclide Therapy in a Patient Participating in the NETTER-1 TrialJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Clinical Nuclear Medicine|January 25, 2020
Successful Intra-arterial Peptide Receptor Radionuclide Therapy of DOTATOC-Negative High-Grade Liver Metastases of a Pancreatic Neuroendocrine Neoplasm Using 177Lu-DOTA-LM3: A Somatostatin Receptor AntagonistJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Clinical Nuclear Medicine|April 2, 2019
Prostate-Specific Membrane Antigen Accumulation in Lower Extremity LymphedemaJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Pageof 6